| abstract |
crystalline form, and, pharmaceutical composition the present invention relates to crystalline forms of dihydropyrimidine derivatives, and pharmaceutical compositions comprising the crystalline forms described herein, which can be used to prevent, control, treat or lessen the severity of a disease viral in a patient, especially hepatitis b infection or a disease caused by hepatitis b infection. |